Gene · 4610
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and Transcriptomic Features of Relapsed SCLC. | J Thorac Oncol | 2026 | 42749049 | PubTator, text mining | PubMed |
| Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability. | BioDrugs | 2026 | 42684666 | PubTator, text mining | PubMed |
| CMA-associated cellular state remodeling defines prognostic heterogeneity and identifies ARRDC3 as a protective functional gene in small cell lung cancer. | Front Cell Dev Biol | 2026 | 42564958 | PubTator, text mining | PubMed |
| Inhibition of the ATR-CHK1 signaling pathway sensitizes MCPyV-positive Merkel cell carcinoma to gemcitabine. | BMC Cancer | 2026 | 42458330 | PubTator, text mining | PubMed |
| The MYC network: Hub of malignancy and blueprint for intervention. | Biochim Biophys Acta Rev Cancer | 2026 | 42385913 | PubTator, text mining | PubMed |
| Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models. | J Clin Invest | 2026 | 42383359 | PubTator, text mining | PubMed |
| The Genomic Landscape of MYC-, MYCL-, and MYCN-Amplified Solid Tumors. | Clin Cancer Res | 2026 | 42340371 | PubTator, text mining | PubMed |
| Structure and function of the L-MYC N-terminus impacts strategies to inhibit the MYC family of oncoproteins. | Biochem J | 2026 | 42030451 | PubTator, text mining | PubMed |
| A MYC family switch: L-MYC drives and maintains neuroendocrine lineage programs in prostate cancer. | Neoplasia | 2026 | 42001796 | PubTator, text mining | PubMed |
| Establishment of an induced pluripotent stem cell line BTHBIOi003-A from a Leber's congenital amaurosis patient. | Stem Cell Res | 2026 | 42000543 | PubTator, text mining | PubMed |
| RLF/ZFP292 stabilize CoREST-linked LSD1 engagement at bivalent promoters to safeguard pluripotency. | Cell Rep | 2026 | 41996247 | PubTator, text mining | PubMed |
| Formaldehyde activates the RUNX1-ISX axis to promote leukemic reprogramming, a pathway associated with poor prognosis in pediatric B-ALL. | Environ Pollut | 2026 | 41866013 | PubTator, text mining | PubMed |
| TRIM21-Mediated ubiquitination of FBL suppresses PI3K/AKT signaling and tumor progression in clear cell renal cell carcinoma. | Cell Mol Life Sci | 2026 | 41863623 | PubTator, text mining | PubMed |
| PLAAT2 suppresses gastric cancer progression by facilitating cMyc ubiquitination and inhibiting MEK/ERK signaling. | Cell Death Dis | 2026 | 41851102 | PubTator, text mining | PubMed |
| A CDCA2-MYC positive feedback loop controls cancer cells survival. | Open Biol | 2026 | 41844234 | PubTator, text mining | PubMed |
| Subtype-specific dependencies and therapeutic opportunities in small cell lung cancer. | Sci Adv | 2026 | 41824576 | PubTator, text mining | PubMed |
| The dual role of BRD9 in cancer: Mechanistic insights and therapeutic prospects. | iScience | 2026 | 41797932 | PubTator, text mining | PubMed |
| Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer. | Signal Transduct Target Ther | 2026 | 41781386 | PubTator, text mining | PubMed |
| Nucleolus as a cornerstone linking proliferation and metabolism to cellular responses to stress: involvement of transcription factors MYC and p53. | Front Mol Biosci | 2026 | 41777667 | PubTator, text mining | PubMed |
| Identification of multigene predictors of prognosis in patients with ovarian cancer. | iScience | 2026 | 41767263 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4610/papers